HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) SVP Erica Rossitto sold 3,500 shares of the stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the transaction, the senior vice president directly owned 13,426 shares in the company, valued at $6,791,005.06. The trade was a 20.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.
HCA Healthcare Trading Down 0.1%
HCA Healthcare stock traded down $0.62 during midday trading on Tuesday, hitting $504.27. The stock had a trading volume of 1,088,555 shares, compared to its average volume of 1,352,859. The business has a fifty day moving average price of $445.41 and a 200 day moving average price of $445.45. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a market cap of $105.34 billion, a P/E ratio of 16.71, a P/E/G ratio of 1.71 and a beta of 1.11.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The company had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. HCA Healthcare’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.96 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is currently 10.34%.
Institutional Investors Weigh In On HCA Healthcare
Several large investors have recently added to or reduced their stakes in HCA. BlackRock Inc. acquired a new position in shares of HCA Healthcare during the second quarter valued at $5,069,974,000. Wellington Management Group LLP grew its position in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Darsana Capital Partners LP increased its holdings in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after acquiring an additional 350,000 shares during the period. Legal & General Group Plc bought a new stake in HCA Healthcare in the 2nd quarter valued at about $410,992,000. Finally, Jupiter Topco LLC acquired a new position in HCA Healthcare during the 2nd quarter valued at about $371,138,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
HCA has been the topic of a number of research reports. The Goldman Sachs Group dropped their target price on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. TD Cowen lifted their price target on shares of HCA Healthcare from $460.00 to $486.00 and gave the company a “buy” rating in a report on Wednesday, October 28th. BMO Capital Markets initiated coverage on shares of HCA Healthcare in a research report on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 price objective for the company. Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Finally, Bank of America raised their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock a “neutral” rating in a report on Wednesday, October 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $480.13.
View Our Latest Analysis on HCA Healthcare
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
